Systematic review / meta-analysis / 2016
Potassium supplementation slightly raised circulating potassium levels without altering renal function.
A meta-analysis synthesized 20 randomized controlled trials involving 1,216 individuals receiving 22 to 140 mmol/day of oral potassium supplements for 2 to 24 weeks. Supplementation caused a minor increase in circulating potassium (WMD 0.14 mmol/L, 95% CI 0.09 to 0.19) and increased 24-hour urinary potassium excretion (45.75 mmol, 95% CI 38.81 to 53.69). Circulating creatinine values remained unchanged compared to control conditions (WMD 0.30 µmol/L, 95% CI -1.19 to 1.78).
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 1,216 participants across 20 randomized trials in 12 countries
- What was measured
- Circulating potassium and creatinine, urinary potassium excretion
THE PAPER
Systematic review and meta-analysis of randomised controlled trials on the effects of potassium supplements on serum potassium and creatinine.
Cappuccio FP, Buchanan LA, Ji C, Siani A, Miller MA. BMJ Open, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.